• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,699.28 -99.76
(-0.19%)
Dow Jones
7,668.45 9.69
(0.13%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,654.81 -161.33
(-1.49%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
108.6464045
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
62.42
7234.73
EPS(TTM)
Face Value()
Div & Yield %
10.9
1
0.15
 

Kapil Raj Finance reports standalone net loss of Rs 0.07 crore in the March 2026 quarter
Apr 15,2026
Net Loss of Kapil Raj Finance reported to Rs 0.07 crore in the quarter ended March 2026 as against net loss of Rs 0.07 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.55 crore in the year ended March 2026 as against net loss of Rs 0.01 crore during the previous year ended March 2025. Sales reported to Rs 0.80 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.